tiprankstipranks
Advertisement
Advertisement

CTKB Stock Latest News

Cytek Biosciences price target lowered to $4.75 from $5.50 at Stephens
The FlyCytek Biosciences price target lowered to $4.75 from $5.50 at Stephens
19d ago
CTKB
Cytek Biosciences price target lowered to $5.50 from $6 at Morgan Stanley
PremiumThe Fly
Cytek Biosciences price target lowered to $5.50 from $6 at Morgan Stanley
19d ago
CTKB
Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures
PremiumCompany Announcements
Cytek Biosciences Faces Rising Risk From U.S.–China Trade Tensions and Tariff Pressures
23d ago
CTKB
Cytek Biosciences Balances Growth Momentum With Cost Pressures
PremiumCompany Announcements
Cytek Biosciences Balances Growth Momentum With Cost Pressures
23d ago
CTKB
Cytek Maintained at Hold as Risk‑Reward Stays Balanced; $5 Price Target Reaffirmed
PremiumRatings
Cytek Maintained at Hold as Risk‑Reward Stays Balanced; $5 Price Target Reaffirmed
24d ago
CTKB
Cytek Biosciences Balances Growth With Margin Strain
PremiumCompany AnnouncementsCytek Biosciences Balances Growth With Margin Strain
3M ago
CTKB
Cytek Biosciences reports preliminary Q4 revenue $62M, consensus $56.99M
Premium
The Fly
Cytek Biosciences reports preliminary Q4 revenue $62M, consensus $56.99M
5M ago
CTKB
Cytek Biosciences price target raised to $5 from $4 at TD Cowen
Premium
The Fly
Cytek Biosciences price target raised to $5 from $4 at TD Cowen
5M ago
CTKB
Cytek Biosciences assumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Cytek Biosciences assumed with an Equal Weight at Morgan Stanley
6M ago
CTKB
Cytek Biosciences price target lowered to $7.50 from $8 at Piper Sandler
PremiumThe Fly
Cytek Biosciences price target lowered to $7.50 from $8 at Piper Sandler
7M ago
CTKB
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth
PremiumCompany Announcements
Cytek Biosciences Earnings Call: Mixed Sentiment and Growth
7M ago
CTKB
Cytek Biosciences Reports Modest Revenue Growth in Q3 2025
PremiumCompany Announcements
Cytek Biosciences Reports Modest Revenue Growth in Q3 2025
7M ago
CTKB
Cautious Hold on Cytek Biosciences Amid Market Stagnation and Growth Uncertainty
PremiumRatingsCautious Hold on Cytek Biosciences Amid Market Stagnation and Growth Uncertainty
7M ago
CTKB
Cytek Biosciences backs FY25 revenue view $196M-$205M, consensus $195.95M
Premium
The Fly
Cytek Biosciences backs FY25 revenue view $196M-$205M, consensus $195.95M
7M ago
CTKB
Cytek Biosciences reports Q3 EPS (4c), consensus 1c
Premium
The Fly
Cytek Biosciences reports Q3 EPS (4c), consensus 1c
7M ago
CTKB
Cytek Biosciences management to meet virtually with Piper Sandler
PremiumThe Fly
Cytek Biosciences management to meet virtually with Piper Sandler
9M ago
CTKB
Cytek Biosciences price target lowered to $4 from $7 at Morgan Stanley
PremiumThe Fly
Cytek Biosciences price target lowered to $4 from $7 at Morgan Stanley
10M ago
CTKB
Cytek Biosciences Earnings Call Reveals Mixed Outlook
PremiumCompany Announcements
Cytek Biosciences Earnings Call Reveals Mixed Outlook
10M ago
CTKB
Cytek Biosciences: Q2 2025 Financial Performance Overview
PremiumCompany Announcements
Cytek Biosciences: Q2 2025 Financial Performance Overview
10M ago
CTKB
Cytek Biosciences Faces Market Challenges and Uncertain Growth Prospects Leading to Hold Rating
PremiumRatingsCytek Biosciences Faces Market Challenges and Uncertain Growth Prospects Leading to Hold Rating
10M ago
CTKB
Cytek Biosciences reports Q2 EPS (4c), consensus (1c)
Premium
The Fly
Cytek Biosciences reports Q2 EPS (4c), consensus (1c)
10M ago
CTKB
Cytek Biosciences narrows FY25 revenue view to $196M-$200M from $196M-$210M
Premium
The Fly
Cytek Biosciences narrows FY25 revenue view to $196M-$200M from $196M-$210M
10M ago
CTKB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >